M CLOPIDOGREL (is an active metabolite) | CLOPIDOGREL | ATC B01AC04
BLOOD ANTICOAGULANT PLATELET AGGREGATION INHIBITOR ANTITHROMBOTIC ANTIANGINAL FIBRINOLYTIC AGENTS TREATMENT OF ACUTE CORONARY SYNDROME, MYOCARDIAL INFARCTION, STROKE ACTION THROUGH IRREVERSIBLE BINDING OF ITS METABOLITE | - | Cmax 64.7 NANOMOLAR (300 MILLIGRAM) Tmax 0.75 HOUR HT 0.5 HOUR | P2Y PURINOCEPTOR 12 | PURINERGIC RECEPTOR P2Y12 ANTAGONIST CHEMBL2001 PURINERGIC RECEPTOR P2Y12 Q9H244 P2Y PURINOCEPTOR 12 HOMO SAPIENS MEMBRANE RECEPTOR 7TM1 SMALLMOL NUCLEOTIDE-LIKE RECEPTOR PURINE RECEPTOR | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |